MRVI Crosses Above Average Analyst Target
August 04, 2021 at 08:47 AM EDT
In recent trading, shares of Maravai LifeSciences Holdings Inc (MRVI) have crossed above the average analyst 12-month target price of $47.28, changing hands for $47.72/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrade on valuation, or, re-adjust their target price to a higher level..